These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7323739

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Nagel R, Köllin CP.
    Br J Urol; 1977 Feb; 49(1):73-9. PubMed ID: 837052
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism.
    Gustafson A, Persson B, Tisell LE, Wiklund O, Ohlson R.
    Invest Urol; 1977 Nov; 15(3):220-4. PubMed ID: 591268
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
    Bergenheim AT, Gunnarsson PO, Edman K, von Schoultz E, Hariz MI, Henriksson R.
    Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Estracyt, new therapeutic agent for cancer of the prostate].
    Bouffioux C, de Leval J.
    Rev Med Liege; 1980 Dec 15; 35(24):865-70. PubMed ID: 7209203
    [No Abstract] [Full Text] [Related]

  • 38. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Dec 15; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 39. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May 15; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 40. Treatment of prostatic carcinoma with estramustine phosphate (Estracyt).
    Benson RC.
    Wis Med J; 1976 Sep 15; 75(9):S89-90. PubMed ID: 969557
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.